Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Regenmortel, N
Right arrow Articles by Schroyens, W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Regenmortel, N
Right arrow Articles by Schroyens, W
Haematologica, Vol 90, Issue 12_Suppl, ECR43-ECR43
Copyright © 2005 by Ferrata Storti Foundation


Case Reports

Bortezomib-induced Sweet's syndrome

N Van Regenmortel, K Van de Voorde, H De Raeve, S Rombouts, A Van de Velde, J Lambert, and W Schroyens

Division of Haematology, Antwerp University Hospital.

Sweet's syndrome is an uncommon acute skin disease, associated with a variety of medical problems. The drug-induced variant is even rarer. We describe two cases of this syndrome associated with the administration of the proteasome inhibitor bortezomib. The diagnostic criteria for drug-induced Sweet's syndrome as proposed by Walker and Cohen were fulfilled. Vasculitis and neutrophilic eccrine hidradenitis were excluded.





HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 2005 by the Ferrata Storti Foundation.